BrightPath Biotherapeutics Co., Ltd.
4594.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | ¥810,470 | ¥1,057,360 | ¥1,530,969 | ¥2,305,026 |
| Short-Term Investments | ¥0 | ¥0 | ¥0 | ¥0 |
| Receivables | ¥64,679 | ¥6 | ¥55 | ¥16,586 |
| Inventory | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Curr. Assets | ¥13,127 | ¥123,594 | ¥120,186 | ¥374,438 |
| Total Curr. Assets | ¥1,071,315 | ¥1,180,960 | ¥1,651,210 | ¥2,696,050 |
| Property Plant & Equip (Net) | ¥0 | ¥0 | ¥0 | ¥24,918 |
| Goodwill | ¥0 | ¥0 | ¥0 | ¥0 |
| Intangibles | ¥0 | ¥0 | ¥0 | ¥0 |
| Long-Term Investments | ¥0 | ¥0 | ¥0 | ¥0 |
| Tax Assets | ¥0 | ¥0 | ¥0 | ¥0 |
| Other NC Assets | ¥49,297 | ¥49,296 | ¥50,234 | ¥50,234 |
| Total NC Assets | ¥49,297 | ¥49,296 | ¥50,234 | ¥75,152 |
| Other Assets | ¥0 | ¥1 | ¥0 | ¥0 |
| Total Assets | ¥1,120,612 | ¥1,230,257 | ¥1,701,444 | ¥2,771,202 |
| Liabilities | – | – | – | – |
| Payables | ¥35 | ¥20 | ¥77 | ¥1,912 |
| Short-Term Debt | ¥25,000 | ¥112,500 | ¥0 | ¥87,500 |
| Tax Payable | ¥0 | ¥12,815 | ¥10,409 | ¥38,817 |
| Deferred Revenue | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Curr. Liab. | ¥89,558 | ¥65,676 | ¥66,072 | ¥56,426 |
| Total Curr. Liab. | ¥131,661 | ¥191,011 | ¥76,558 | ¥184,655 |
| LT Debt | ¥0 | ¥0 | ¥0 | ¥0 |
| Deferred Rev, NC | ¥0 | ¥0 | ¥0 | ¥0 |
| Deferred Tax Liab, NC | ¥0 | ¥0 | ¥0 | ¥0 |
| Other NC Liab. | ¥63,962 | ¥60,258 | ¥57,347 | ¥55,073 |
| Total NC Liab. | ¥63,962 | ¥60,260 | ¥57,347 | ¥55,073 |
| Other Liabilities | ¥0 | ¥0 | ¥0 | ¥0 |
| Cap. Leases | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Liabilities | ¥195,623 | ¥251,271 | ¥133,905 | ¥239,728 |
| Equity | – | – | – | – |
| Pref Stock | ¥0 | ¥0 | ¥0 | ¥0 |
| Common Stock | ¥1,199,869 | ¥650,661 | ¥362,185 | ¥6,700,382 |
| Retained Earnings | -¥3,804,864 | -¥2,653,715 | -¥1,485,633 | -¥10,875,815 |
| AOCI | ¥21,580 | ¥22,845 | ¥20,268 | ¥22,940 |
| Other Equity | ¥1 | ¥0 | ¥0 | ¥0 |
| Total Equity | ¥924,987 | ¥978,986 | ¥1,567,539 | ¥2,531,474 |
| Supplemental Information | – | – | – | – |
| Minority Interest | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Liab. & Tot. Equity | ¥1,120,612 | ¥1,230,257 | ¥1,701,444 | ¥2,771,202 |
| Net Debt | -¥785,470 | -¥944,860 | -¥1,530,969 | -¥2,217,526 |